EliasAGiraldoMDMS

Vascular Neurology

Chief of Neurology National Brain Injury Institute, Los Angeles, California

Dr. Giraldo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

I am a board certified neurologist and vascular neurologist with training in neurosurgery in Peru, and neurology, and vascular and critical care neurology in the USA. I am Chief of Neurology at National Brain Injury Institute in Los Angeles, and former Chair and Professor of Neurology at California University of Science and Medicine. I have published over 60 abstracts, book chapters, and peer-reviewed papers.

University of TennesseeMS, Epidemiology, 2006 - 2008
Sidney Kimmel Medical College at Thomas Jefferson UniversityFellowship, Cerebrovascular Diseases & Neurological Critical Care, 2000 - 2001
University of Vermont Medical CenterResidency, Neurology, 1997 - 2000
National University of San MarcosClass of 1990

PubMed

Holohemispheric Intracranial Subdural Empyema as a Complication of Orbital Cellulitis.
Hadi Abou-El-Hassan, Yosof Katiby, Elias A Giraldo
Cureus. 2024-04-01
The 100 Most Cited Kluver-Bucy Research Articles: A Bibliometric Analysis.
Cynthia Janku, Priya V Engel, Kisan Patel, Elias Giraldo
Cureus. 2023-09-01
3 citations
Isolated Cortical Vein Thrombosis Associated with Prothrombin Gene Mutation
Elias A. Giraldo, Rohan Arora, Robert A. Koenigsberg
Journal of Stroke and Cerebrovascular Diseases. 2014-04-01

Association of Apolipoprotein E with Intracerebral Hemorrhage Risk by Race/Ethnicity: A Meta-AnalysisApril 1st, 2020

Education Program for Stroke Survivors at the Stroke Center (REVISE)Tennessee Department of Health2009–2010
Unrestricted Educational Grant: Ischemic Stroke Management Program to Prevent Vascular Events (IMPROVE)Boehringer Ingelheim Pharmaceuticals, Inc.2005–2006
Unrestricted Educational Grant: Guest Lecturer: Early Management of Patients with Ischemic StrokeBoehringer Ingelheim Pharmaceuticals, Inc.2004

Elected Member, American Medical Association Academic Physicians Section 2016 - Present
Member, American Academy of Neurology Donald M. Palatucci Advocacy Leadership Group 2007 - Present
Chair, American Neurology Association Public Policy and Relations Committee 2020 - 2021
Vice-Chair, American Neurology Association Public Policy and Relations Committee 2019 - 2020
Member, American Neurological Association Public Policy and Relations 2016 - 2019

Principal InvestigatorAsubio Pharmaceuticals ASBI 802 Trial2014 - 2015
Principal InvestigatorInvestigator-Initiated Education Program for Stroke Survivors at the Stroke Center (REVISE) Tennessee Department of Health2009 - 2010
Principal InvestigatorNational Institutes of Health IRIS Trial2006 - 2009
Principal InvestigatorNovo Nordisk FAST Trial2005 - 2007
Principal InvestigatorInvestigator-Initiated Ischemic Stroke Management Program to Prevent Vascular Events (IMPROVE) Boehringer-Ingelheim Pharmaceuticals, Inc.2005 - 2006
Principal InvestigatorAventis Pharma PREVAIL Trial2003 - 2005